Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
In Diagnostics launches a $30 test that aims to tell you if your liver is working

From TechCrunch

By Haje Jan Kamps

September 19, 2023

In Diagnostics launches a $30 test that aims to tell you if your liver is working

If you’re rushed to the hospital and into emergency surgery, it would be helpful if the anesthesiology team could predict whether your body will react in the way they expect. In the majority of cases, things work out just fine, but if a patient has liver failure, things can get hairy pretty fast. Over time, […]
<!-- entity-linker:completed v1 -->

Most Recent

Travis Kalanick’s robotics company raises $1.7B, led by a16z

Travis Kalanick’s robotics company raises $1.7B, led by a16z

Uber is also investing in Travis Kalanick's company Atoms, which has made gauzy claims about using industrial AI to modernize the world.

Jul 22, 2026

Arcee, a US open source AI lab, says Chinese models are not inherently dangerous

Arcee, a US open source AI lab, says Chinese models are not inherently dangerous

As Chinese AI models grow in capability and popularity among U.S. companies, the arguing over what should be done about them has reached a fever pitch.

Jul 22, 2026

Cascade raises $3.5M to help construction firms find and win projects

Cascade raises $3.5M to help construction firms find and win projects

a16z Speedrun, Ada Ventures, and Snowball VC have invested in Cascade's $3.5 million seed round.

Jul 22, 2026

The browser wars aren’t about search anymore — here are the best alternatives to Chrome and Safari

The browser wars aren’t about search anymore — here are the best alternatives to Chrome and Safari

We’ve compiled an overview of some of the top alternative browsers available today aiming to challenge Chrome and Safari.

Jul 22, 2026

Similar Posts

How AI startup Conflixis is protecting hospitals from corrupt doctors

How AI startup Conflixis is protecting hospitals from corrupt doctors

After a career as an incident investigator with risk management firms like Kroll and FTI Consulting, Aaron Narva (pictured above) was working with a big international bank client at compliance software maker Exiger. He was responsible for monitoring that client’s legal compliance after it had made headlines a decade earlier for a money-laundering scandal. “While I was at Exiger, we acquired some software businesses, including an AI software tool that helped pull risk out of unstructured public

Nov 8, 2024

Keep’s AIOps platform helps ops teams reduce alert fatigue

Keep’s AIOps platform helps ops teams reduce alert fatigue

Alert management for developers and ops teams may seem like a solved problem. Notifying an on-call engineer isn’t exactly difficult anymore, after all. But the real question has become when to alert the right person and how to help them when a service goes down, for example. Many are turning to AI to solve some of those issues, including Keep. The company offers an open source version that uses a rule-based system, but what’s more interesting is its paid enterprise offering, which also uses AI

Oct 15, 2024

Miraqules will showcase its blood clotting technology at TechCrunch Disrupt 2025

Miraqules will showcase its blood clotting technology at TechCrunch Disrupt 2025

India-based Miraqules developed a nanotechnology that mimics blood clotting proteins to quickly stop heavy bleeding.

Oct 27, 2025

Londoners will soon see drones ferrying blood between hospitals

Londoners will soon see drones ferrying blood between hospitals

As part of a new, joint pilot program by U.K. startup Apian, Alphabet’s drone company Wing, and the U.K.’s National Health Service, drones will soon be used to fly urgent blood samples between two hospitals in London. As part of the six-month pilot program, drones will deliver urgently required blood samples for surgery patients — at high risk of complications from bleeding disorders — between Guy’s Hospital and St Thomas’ Hospital in London. Deliveries that used to take vans or motorbikes mor

Sep 17, 2024

Most Recent

Travis Kalanick’s robotics company raises $1.7B, led by a16z

Travis Kalanick’s robotics company raises $1.7B, led by a16z

Uber is also investing in Travis Kalanick's company Atoms, which has made gauzy claims about using industrial AI to modernize the world.

Jul 22, 2026

Arcee, a US open source AI lab, says Chinese models are not inherently dangerous

Arcee, a US open source AI lab, says Chinese models are not inherently dangerous

As Chinese AI models grow in capability and popularity among U.S. companies, the arguing over what should be done about them has reached a fever pitch.

Jul 22, 2026

Cascade raises $3.5M to help construction firms find and win projects

Cascade raises $3.5M to help construction firms find and win projects

a16z Speedrun, Ada Ventures, and Snowball VC have invested in Cascade's $3.5 million seed round.

Jul 22, 2026

The browser wars aren’t about search anymore — here are the best alternatives to Chrome and Safari

The browser wars aren’t about search anymore — here are the best alternatives to Chrome and Safari

We’ve compiled an overview of some of the top alternative browsers available today aiming to challenge Chrome and Safari.

Jul 22, 2026

Similar Posts

How AI startup Conflixis is protecting hospitals from corrupt doctors

How AI startup Conflixis is protecting hospitals from corrupt doctors

After a career as an incident investigator with risk management firms like Kroll and FTI Consulting, Aaron Narva (pictured above) was working with a big international bank client at compliance software maker Exiger. He was responsible for monitoring that client’s legal compliance after it had made headlines a decade earlier for a money-laundering scandal. “While I was at Exiger, we acquired some software businesses, including an AI software tool that helped pull risk out of unstructured public

Nov 8, 2024

Keep’s AIOps platform helps ops teams reduce alert fatigue

Keep’s AIOps platform helps ops teams reduce alert fatigue

Alert management for developers and ops teams may seem like a solved problem. Notifying an on-call engineer isn’t exactly difficult anymore, after all. But the real question has become when to alert the right person and how to help them when a service goes down, for example. Many are turning to AI to solve some of those issues, including Keep. The company offers an open source version that uses a rule-based system, but what’s more interesting is its paid enterprise offering, which also uses AI

Oct 15, 2024

Miraqules will showcase its blood clotting technology at TechCrunch Disrupt 2025

Miraqules will showcase its blood clotting technology at TechCrunch Disrupt 2025

India-based Miraqules developed a nanotechnology that mimics blood clotting proteins to quickly stop heavy bleeding.

Oct 27, 2025

Londoners will soon see drones ferrying blood between hospitals

Londoners will soon see drones ferrying blood between hospitals

As part of a new, joint pilot program by U.K. startup Apian, Alphabet’s drone company Wing, and the U.K.’s National Health Service, drones will soon be used to fly urgent blood samples between two hospitals in London. As part of the six-month pilot program, drones will deliver urgently required blood samples for surgery patients — at high risk of complications from bleeding disorders — between Guy’s Hospital and St Thomas’ Hospital in London. Deliveries that used to take vans or motorbikes mor

Sep 17, 2024